Lombard, A.* , Isci, D.* , Reuter, G., Di Valentin, E., Hego, A., Martin, D., Rogister, B., & Neirinckx, V. (In press). Development of an intraventricular Adeno-Associated Virus-based labelling strategy for glioblastoma cells nested in the subventricular zone. Neuro-Oncology Advances. Neuro-Oncology Advances. * These authors have contributed equally to this work. |
D'Uonnolo, G.* , Isci, D.* , Nosirov, B., Kuppens, A., Wantz, M., Nazarov, P., Golebiewska, A., Rogister, B., Chevigné, A.* , Neirinckx, V.* , & Szpakowska, M.*. (November 2024). Patient-based multilevel transcriptome exploration highlights relevant chemokines and chemokine receptor axes in glioblastoma. Computers in Biology and Medicine, 182, 109197. doi:10.1016/j.compbiomed.2024.109197 * These authors have contributed equally to this work. |
Waked, A., Crabbé, M., Neirinckx, V., Rogister, B., Benotmane, M. A., & Vermeulen, K. (26 April 2024). Preclinical evaluation of 177Lu-radiolabelled CXCR4-targeting peptides for glioblastoma therapy [Poster presentation]. 9th Symposium on Medical Radioisotopes (ISMERAD) | Alpha Therapy: New approaches in radionuclide therapy, Ghent, Belgium. |
Isci, D., Kuppens, A., Scalisi, J., COKAIKO, J., Wantz, M., Szpakowska, M., Chevigné, A., Rogister, B., & Neirinckx, V. (2024). Heterogeneous expression of the atypical chemokine receptor ACKR3 in glioblastoma patient-derived tissue samples and cell cultures. Scientific Reports, 14, 21925. doi:10.1038/s41598-024-73064-w |
Waked, A., Crabbé, M., Neirinckx, V., Rodriguez Pérez, S., Wellens, J., Rogister, B., Benotmane, A., & Vermeulen, K. (2024). Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma. EJNMMI Radiopharmacy and Chemistry. doi:10.1186/s41181-024-00282-y |
Simonet, A., Isci, D., Neirinckx, V., Jerusalem, G., & Rogister, B. (06 December 2023). 190P Immune-related roles of B7H3 in glioblastoma [Poster presentation]. ESMO Immuno-oncology. doi:10.1016/j.iotech.2023.100649 |
Da Veiga, M.-A., Coppieters't Wallant, N., Lombard, A., Rogister, B., Neirinckx, V.* , & Piette, C.*. (16 June 2023). Comprehensive profiling of stem-like features in pediatric glioma cell cultures and their relation to the subventricular zone. Acta Neuropathologica Communications, 11 (1), 96. doi:10.1186/s40478-023-01586-x * These authors have contributed equally to this work. |
Coppieters, N., Scalisi, J., Di Gregorio, M., Leparc, L., Velazquez Saez, L., Lombard, A., Rogister, B., & Neirinckx, V. (2023). Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma. Journal of Neuro-Oncology. doi:10.1007/s11060-023-04240-7 |
Dosquet, H., Neirinckx, V., Meyrath, M., Wantz, M., Haan, S., Niclou, S. P., Szpakowska, M., & Chevigné, A. (2023). Nanoluciferase-based complementation assays to monitor activation, modulation and signaling of receptor tyrosine kinases (RTKs). Methods in Enzymology, 682, 1 - 16. doi:10.1016/bs.mie.2022.09.002 |
Sanchez Gil, J., Dubois, M., Neirinckx, V., LOMBARD, A., Coppieters't Wallant, N., D'arrigo, P., Isci, D., Aldenhoff, T., Brouwers, B., Lassence, C., ROGISTER, B., Lebrun, M., & Sadzot, C. (2022). Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: a proof-of-principle. Molecular Therapy: Oncolytics. doi:10.1016/j.omto.2022.06.002 |
Da Veiga, M.-A., Rogister, B., LOMBARD, A., Neirinckx, V.* , & PIETTE, C.*. (04 May 2022). Glioma Stem Cells in Pediatric High-Grade Gliomas: From Current Knowledge to Future Perspectives. Cancers, 14 (9), 2296. doi:10.3390/cancers14092296 * These authors have contributed equally to this work. |
Isci, D., Veiga, D., Cokaiko, J., LOMBARD, A., Chevigné, A., ROGISTER, B., & Neirinckx, V. (10 April 2022). Study of the ACKR3/CXCR7 receptor in glioblastoma [Poster presentation]. Télévie Seminar, Liège, Belgium. |
Bartholomé, O., Neirinckx, V., & Rogister, B. (2022). SV2A absence in GABAergic neurons induces seizure in a conditional KO model [Poster presentation]. FENS 2022, Paris, France. |
Isci, D.* , D'Uonnolo, G.* , Wantz, M., Rogister, B., LOMBARD, A., Chevigné, A., Szpakowska, M., & Neirinckx, V. (28 December 2021). Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma. Cancers, 14 (1), 130. doi:10.3390/cancers14010130 * These authors have contributed equally to this work. |
Sanchez Gil, J., D'arrigo, P., Neirinckx, V., Isci, D., Brouwers, B., LOMBARD, A., Rogister, B., Lebrun, M., & Sadzot, C. (2021). Targeting of CXCR4+ Glioblastoma initiating cells with a retargeted Oncolytic Herpesvirus (oHSV): proof of concept [Paper presentation]. IHW2021: 45th International Herpesvirus Workshop. |
Wislet-Gendebien, S., Poulet, C., Neirinckx, V., Hennuy, B., Swingland, J. T., Laudet, E., Sommer, L., Shakova, O., Bours, V., & Rogister, B. (2021). Correction: In Vivo Tumorigenesis Was Observed after Injection of In Vitro Expanded Neural Crest Stem Cells Isolated from Adult Bone Marrow. PLoS ONE, 16 (9), 0256477. doi:10.1371/journal.pone.0256477 |
Schuster, A., Klein, E., Neirinckx, V., Moldrup Knudsen, A., Fabian, C., Hau, A.-C., Dieterle, M., Nazarov, P., Golebiewska, A., Muller, A., Perez Hernandez, D., Rodius, S., Dittmar, G., Bjerkvig, R., Herold-Mende, C., Klink, B., Winther Christensen, B., & Niclou, S. (11 December 2020). AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion. Nature Communications, 11 (1), 6366. doi:10.1038/s41467-020-20029-y |
Golebiewska, A., Hau, A.-C., Oudin, A., Stieber, D., Yabo, Y., Baus, V., Barthélémy, V., Klein, E., Bougnaud, S., Keunen, O., Wantz, M., Michelucci, A., Neirinckx, V., Muller, A., Kaoma, T., Nazarov, P., Azuaje, F., De Falco, A., Flies, B., ... Niclou, S. (December 2020). Primary and recurrent glioma patient-derived orthotopic xenografts (PDOX) represent relevant patient avatars for precision medicine. Acta Neuropathologica, 140 (6), 919-949. doi:10.1007/s00401-020-02226-7 |
Bartholomé, O., Van den ackerveken, P., de la Brassinne, O., Neirinckx, V., & Rogister, B. (11 July 2020). Only GABAergic neurons induced seizures following SV2A recombination [Poster presentation]. Federation of European Neuroscience Societies (FENS). |
Bartholomé, O., de la Brassinne Bonardeaux, O., Neirinckx, V., & Rogister, B. (2020). A Composite Sketch of Fast-spiking Parvalbumin-positive Neurons. Cerebral Cortex Communications. doi:10.1093/texcom/tgaa026 |
Neirinckx, V., Hau, A.-C., Schuster, A., Fritah, S., Chevigné, A., Schmidt, M. H. H., & Niclou, S. P. (September 2019). Pan-RTK inhibition of sLRIG1 mediates AXL downregulation in Glioblastoma. Neuro-Oncology, 21 (Supp 3). doi:10.1093/neuonc/noz126.155 |
Neirinckx, V., Hau, A.-C., Schuster, A., Fritah, S., Tiemann, K., Klein, E., Nazarov, P. V., Matagne, A., Szpakowska, M., Meyrath, M. M. R., Chevigné, A., Schmidt, M. H. H., & Niclou, S. P. (September 2019). The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein–protein interaction in glioblastoma. Neuro-Oncology Advances, 1 (1). doi:10.1093/noajnl/vdz024 |
Neirinckx, V., Schuster, A., Chevigné, A., Schmidt, M. H. H., & Niclou, S. (September 2018). Harnessing soluble LRIG1 for pan-RTK targeting in glioblastoma. Neuro-Oncology, 20 (Supp 3). doi:10.1093/neuonc/noy139.011 |
Neirinckx, V., Hedman, H., & Niclou, S. P. (August 2017). Harnessing LRIG1-mediated Inhibition of Receptor Tyrosine Kinases for Cancer Therapy. Biochimica et Biophysica Acta. Reviews on Cancer, 1868 (1), 109-116. doi:10.1016/j.bbcan.2017.02.007 |
Coste, C., Neirinckx, V., Sharma, A., Agirman, G., Rogister, B., FOGUENNE, J., Lallemend, F., Gothot, A., & Wislet, S. (2017). Human bone marrow harbors cells with neural crest-associated characteristics like human adipose and dermis tissues. PLoS ONE, 12 (7), 0177962. doi:10.1371/journal.pone.0177962 |
Coste, C., Neirinckx, V., Rogister, B., Gothot, A., & Wislet, S. (25 January 2016). Human Adult Bone Marrow and Adipose Tissue Harbor Stem Cells with Neural Crest Characteriscs [Poster presentation]. GIGA Day, Liège, Belgium. |
Lombard, T., Neirinckx, V., Rogister, B., Gilon, Y., & Wislet, S. (2016). Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches. Stem Cells International. doi:10.1155/2016/8768162 |
MENTEN, C.* , Serrano Navacerrada, M. E.* , Bartholomé, O., Gil, J. S., Neirinckx, V., Wislet, S., Becker, G., Plenevaux, A., Van Den Ackerveken, P.* , & Rogister, B.*. (2016). Development and validation of a new mouse model to investigate the role of sv2a in epilepsy. PLoS ONE. doi:10.1371/journal.pone.0166525 * These authors have contributed equally to this work. |
Neirinckx, V., Agirman, G., Coste, C., Marquet, A., Dion, V., Rogister, B., Franzen, R., & Wislet, S. (November 2015). Adult bone marrow mesenchymal and neural crest stem cells are chemoattractive and accelerate motor recovery in a mouse model of spinal cord injury. Stem Cell Research and Therapy, 6 (211). doi:10.1186/s13287-015-0202-2 |
Neirinckx, V. (2015). Etude des sous-populations de cellules souches stromales de la moelle osseuse, et de leur utilisation dans des protocoles de thérapie pour les maladies du système nerveux central [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315399 |
Coste, C., Neirinckx, V., Gothot, A., Wislet, S., & Rogister, B. (2015). Are neural crest stem cells the missing link between hematopoietic and neurogenic niches? Frontiers in Cellular Neuroscience. doi:10.3389/fncel.2015.00218 |
Coste, C., Neirinckx, V., Rogister, B., Gothot, A., & Wislet, S. (2015). Human Adult Bone Marrow and Adipose Tissue Present Stem Cells with Neural Crest Characteristics. Cytotherapy. doi:10.1016/j.jcyt.2015.03.427 |
Neirinckx, V., Agirman, G., Coste, C., Rogister, B., Franzen, R., & Wislet, S. (2015). Exploring the secretome of bone marrow mesenchymal and neural crest-derived stem cells for treating spinal cord injuries. Cytotherapy. doi:10.1016/j.jcyt.2015.03.502 |
Neirinckx, V. (11 March 2015). Adult bone marrow stem cells-derived chemokines for treating spinal cord injuries [Paper presentation]. European Winter Conference on Brain Research, Brides-les-Bains, France. |
Wislet, S., Coste, C., Neirinckx, V., & Rogister, B. (March 2015). Differential membrane marker expression in adult rodent bone marrow mesenchymal and neural crest stem cells [Poster presentation]. International Society for Cellular therapy 2015, Las Vegas, United States. |
Coste, C., Neirinckx, V., Rogister, B., Gothot, A., & Wislet, S. (21 January 2015). Human Adult Bone Marrow and Adipose Tissue Present Stem Cells with Neural Crest Characteristics [Poster presentation]. GIGA DAY. |
Neirinckx, V., Agirman, G., Marquet, A., Coste, C., Dion, V., Rogister, B., Franzen, R., & Wislet, S. (17 November 2014). Specific properties of bone marrow mesenchymal and neural crest-derived stem cells: Relevance in spinal cord injury therapy [Poster presentation]. Neuroscience 2014, Washington DC, United States. |
Neirinckx, V., Agirman, G., Rogister, B., Franzen, R., & Wislet, S. (25 September 2014). Bone marrow mesenchymal and neural crest-derived stem cells have distinct secretomes, which are both relevant for spinal cord injury therapy [Paper presentation]. 9th Congress of the International Society for NeuroImmunoModulation. |
Neirinckx, V., Coste, C., Franzen, R., Gothot, A., Rogister, B., & Wislet, S. (28 August 2014). Neutrophil contribution to spinal cord injury and repair. Journal of Neuroinflammation, 11 (1). doi:10.1186/s12974-014-0150-2 |
Neirinckx, V., CANTINIEAUX, D., Coste, C., Rogister, B., Franzen, R., & Wislet, S. (2014). Spinal Cord Injuries – How Could Adult Mesenchymal and Neural Crest Stem Cells Take Up the Challenge? Stem Cells. doi:10.1002/stem.1579 |
Neirinckx, V., Rogister, B., Franzen, R., & Wislet, S. (2014). Bone marrow stromal stem cells transplantation in mice with acute spinal cord injury. Methods in Molecular Biology, 1213. doi:10.1007/978-1-4939-1453-1_21 |
Coste, C., Neirinckx, V., Manguette, J., Rogister, B., Gothot, A., & Wislet, S. (05 December 2013). In vitro and in vivo Characterization of Adult Bone Marrow Neural Crest Stem Cells and their Implication in Hematopoietic Support [Poster presentation]. Journée Télévie, Bruxelles, Belgium. |
Coste, C., Neirinckx, V., Manguette, J., Rogister, B., Gothot, A., & Wislet, S. (12 September 2013). In vitro and in vivo Characterization of Adult Bone Marrow Neural Crest Stem Cells and their Implication in Hematopoietic Support [Poster presentation]. EURON, Liège, Belgium. |
Neirinckx, V. (12 September 2013). Adult bone marrow stem cells in neurological diseases: Protect or repair? [Paper presentation]. EURON PhD days 12-13th Sept 2013. |
Coste, C., Neirinckx, V., Manguette, J., Rogister, B., Gothot, A., & Wislet, S. (31 May 2013). In vitro and in vivo Characterization of Adult Bone Marrow Neural Crest Stem Cells [Poster presentation]. Belgian society of neurosciences, Bruxelles, Belgium. |
Neirinckx, V., Marquet, A., Coste, C., Rogister, B., & Wislet, S. (31 May 2013). Adult Bone Marrow Neural Crest Stem Cells and Mesenchymal Stem Cells are not able to Replace Lost Neurons in Acute MPTP-lesioned Mice. PLoS ONE, 8 (5). doi:10.1371/journal.pone.0064723 |
Neirinckx, V. (12 April 2013). Adult Bone Marrow Neural Crest and Mesenchymal Stem Cells : Which Role in Therapy of Neurological Pathologies ? [Paper presentation]. Cell-based therapies in Central Nervous System Pathology, Hasselt, Belgium. |
Neirinckx, V., Coste, C., Rogister, B., & Wislet, S. (02 April 2013). Adult Mesenchymal Stem Cells, Adult Neural Crest Stem Cells and Therapy of Neurological Pathologies: a State of Play. Stem Cells Translational Medicine, 2 (4), 284-296. doi:10.5966/sctm.2012-0147 |
Neirinckx, V., Coste, C., Rogister, B., & Wislet, S. (2013). Neural fate of Mesenchymal Stem Cells and Neural Crest Stem Cells : Which ways to get neurons for cell therapy purpose ? In Trends in cell signaling pathways in neuronal fate decision (pp. 327-358). Croatia: InTech. |
Coste, C., Neirinckx, V., Rogister, B., Gothot, A., & Wislet, S. (28 January 2013). In vitro and in vivo Characterization of Adult Bone Marrow Neural Crest Stem Cells and their Implication in Hematopoietic Support [Poster presentation]. GIGA Day, Liège, Belgium. |
Neirinckx, V., Marquet, A., Poulet, C., Laudet, E., Coste, C., Manguette, J., Rogister, B., & Wislet, S. (28 January 2013). Adult Bone Marrow Neural Crest and Mesenchymal Stem Cells : Which Role in Therapy of Neurological Pathologies ? [Poster presentation]. GIGA Day 2013. |
Coste, C., Neirinckx, V., Rogister, B., Gothot, A., & Wislet, S. (10 December 2012). In vitro and in vivo Characterization of Adult Bone Marrow Neural Crest Stem Cells and their Implication in Hematopoietic Support [Poster presentation]. TELEVIE's Researchers Seminar, Liège, Belgium. |
Wislet, S.* , Poulet, C.* , Neirinckx, V., Hennuy, B., Swingland, J., Laudet, E., Sommer, L., Shakhova, O., Bours, V., & Rogister, B. (October 2012). In Vivo Tumorigenesis Was Observed after Injection of In Vitro Expanded Neural Crest Stem Cells Isolated from Adult Bone Marrow. PLoS ONE, 7 (10), 46425. doi:10.1371/journal.pone.0046425 * These authors have contributed equally to this work. |
Wislet, S., Laudet, E., Neirinckx, V., Alix, P., Leprince, P., glejzer, A., Poulet, C., Hennuy, B., Sommer, L., Shakhova, O., & Rogister, B. (August 2012). [RETRACTED] Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences. Cellular and Molecular Life Sciences, 69 (15), 2593-2608. doi:10.1007/s00018-012-0937-1 |
Neirinckx, V., Laudet, E., Rogister, B., & Wislet, S. (04 May 2012). Validation of Adult Bone Marrow Stromal Cells in Cellular Therapy Protocols, using a Mouse Model for Parkinson’s Disease [Poster presentation]. GIGA Day 2012. |
Neirinckx, V., Rogister, B., & Wislet, S. (2012). Adult neural crest stem cells and neuronal fate decision. In Trends in cell signaling pathways in neuronal fate decision. Croatia: InTech. |
Wislet-Gendebien, S., Laudet, E., Neirinckx, V., & Rogister, B. (2011). Adult bone marrow: which stem cells for cellular therapy protocols in neurodegenerative disorders? Journal of Biomedicine and Biotechnology. |
Neirinckx, V. (2011). Etude in vivo de la plasticité phénotypique nerveuse des cellules souches dérivées de la moelle osseuse adulte [Master’s dissertation, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/136788 |
Glejzer, A., Neirinckx, V., Rogister, B., & Wislet, S. (2011). Neural crest stem cells from adult bone marrow: a new source for cell replacement therapy? In S. Wislet (Ed.), Advance in Regenerative Medicine (pp. 3-18). Croatia: Intech-open access publisher. |